We are live on
!
Find out more
DekaBank Deutsche Girozentrale Portfolio holdings
AUM
$59.2B
1-Year Est. Return
26.02%
This Fund
S&P 500
This Quarter
Est. Return
+11.11%
1 Year Est. Return
+26.02%
3 Year Est. Return
+92.08%
5 Year Est. Return
+125.09%
10 Year Est. Return
+457.34%
AUM
$41.1B
AUM Growth
+$5.37B
(+15%)
Cap. Flow
+$2.44B
Cap. Flow
% of AUM
5.94%
Top 10 Holdings %
Top 10 Hldgs %
24.49%
Holding
1,526
New
158
Increased
755
Reduced
338
Closed
110
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mastercard
MA
|
+$170M |
| 2 |
Tesla
TSLA
|
+$155M |
| 3 |
NVIDIA
NVDA
|
+$116M |
| 4 |
TSMC
TSM
|
+$87.6M |
| 5 |
Nutrien
NTR
|
+$86.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$150M |
| 2 |
Northrop Grumman
NOC
|
+$112M |
| 3 |
Honeywell
HON
|
+$98.1M |
| 4 |
Linde
LIN
|
+$87M |
| 5 |
Uber
UBER
|
+$72.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.6% |
| 2 | Healthcare | 16.16% |
| 3 | Financials | 10.71% |
| 4 | Consumer Discretionary | 9.79% |
| 5 | Communication Services | 8.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1201
SoFi Technologies
SOFI
$23.2B
| $293K | ﹤0.01% |
+19,892
| New | +$365K |
|
|
RAPT
1202
DELISTED
RAPT Therapeutics
RAPT
| $292K | ﹤0.01% |
1,025
+25
| +3% | +$6.68K |
|
1203
Atkore
ATKR
$3.17B
| $291K | ﹤0.01% |
2,569
+763
| +42% | +$77.5K |
|
1204
BWX Technologies
BWXT
$15.5B
| $291K | ﹤0.01% |
6,000
-300
| -5% | -$15.7K |
|
|
RUBY
1205
DELISTED
Rubius Therapeutics, Inc
RUBY
| $289K | ﹤0.01% |
29,000
+800
| +3% | +$11.1K |
|
1206
Aclaris Therapeutics
ACRS
$871M
| $288K | ﹤0.01% |
+20,000
| New | +$303K |
|
1207
Inovio Pharmaceuticals
INO
$79.1M
| $285K | ﹤0.01% |
4,625
+125
| +3% | +$10K |
|
1208
Teva Pharmaceuticals
TEVA
$42.5B
| $284K | ﹤0.01% |
33,683
-121
| -0.4% | -$1.09K |
|
1209
Ryder
R
$9.92B
| $283K | ﹤0.01% |
3,460
+828
| +31% | +$69.4K |
|
1210
Hyatt Hotels
H
$16.3B
| $282K | ﹤0.01% |
2,959
| – | – |
|
1211
Crinetics Pharmaceuticals
CRNX
$8.95B
| $276K | ﹤0.01% |
10,300
+300
| +3% | +$7.4K |
|
1212
Concentrix
CNXC
$1.57B
| $275K | ﹤0.01% |
1,509
+546
| +57% | +$97.4K |
|
|
RPTX
1213
DELISTED
Repare Therapeutics
RPTX
| $275K | ﹤0.01% |
13,300
+400
| +3% | +$9.42K |
|
1214
Jefferies Financial Group
JEF
$12.7B
| $270K | ﹤0.01% |
+7,192
| New | +$277K |
|
1215
Edgewise Therapeutics
EWTX
$4.81B
| $269K | ﹤0.01% |
+18,000
| New | +$324K |
|
1216
Tenaya Therapeutics
TNYA
$168M
| $269K | ﹤0.01% |
+14,000
| New | +$305K |
|
1217
Absci
ABSI
$1.59B
| $268K | ﹤0.01% |
+34,000
| New | +$387K |
|
|
CLR
1218
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $268K | ﹤0.01% |
6,000
-800
| -12% | -$38.1K |
|
|
GTY
1219
Getty Realty Corp
GTY
$2B
| $267K | ﹤0.01% |
+8,407
| New | +$266K |
|
|
NUVL
1220
DELISTED
Nuvalent
NUVL
| $267K | ﹤0.01% |
+14,000
| New | +$312K |
|
1221
Enanta Pharmaceuticals
ENTA
$393M
| $264K | ﹤0.01% |
3,550
+100
| +3% | +$7.85K |
|
1222
Flowserve
FLS
$10.3B
| $264K | ﹤0.01% |
8,500
| – | – |
|
|
AKRO
1223
DELISTED
Akero Therapeutics
AKRO
| $261K | ﹤0.01% |
12,300
+300
| +3% | +$6.65K |
|
1224
MacroGenics
MGNX
$249M
| $261K | ﹤0.01% |
16,600
+400
| +2% | +$7.53K |
|
1225
Arcutis Biotherapeutics
ARQT
$3.3B
| $260K | ﹤0.01% |
12,700
+300
| +2% | +$5.97K |
|
Similar funds
QCM
NAMI
DekaBank Deutsche Girozentrale's Q4 2021 Portfolio in Review
As of Q4 2021, DekaBank Deutsche Girozentrale held 1,526 positions worth $41.1B, up 15% from $35.8B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
DekaBank Deutsche Girozentrale deployed $2.44B of net new capital in Q4 2021, opening 158 new positions and adding to 755 existing holdings. Its largest new stake was Regal Rexnord: 103,299 shares worth $17.6M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Visa, an estimated $150M trimmed.
- DekaBank Deutsche Girozentrale's largest Q4 2021 buy was Regal Rexnord: 103,299 shares worth $17.6M.
- DekaBank Deutsche Girozentrale added most to Mastercard in Q4 2021, an estimated $170M increase.
- DekaBank Deutsche Girozentrale's biggest Q4 2021 reduction was Visa, cutting an estimated $150M.
- DekaBank Deutsche Girozentrale fully exited Kansas City Southern in Q4 2021, selling an estimated $20.2M.
- DekaBank Deutsche Girozentrale's ten largest holdings make up 24% of its $41.1B portfolio in Q4 2021.
- DekaBank Deutsche Girozentrale opened 158 new positions and closed 110 in Q4 2021.
- DekaBank Deutsche Girozentrale's portfolio value rose 15% quarter-over-quarter to $41.1B.
Based on DekaBank Deutsche Girozentrale's 13F filing for Q4 2021, filed 2 Feb 2022.